PPT-Supplemental Chapter: Business Intelligence

Information Systems Development Learning Objectives Upon successful completion of this chapter you will be able to Explain the difference between BI Analytics Data Marts and Big Data Define the characteristics of data for good decision making. Luc Janssen. Director, Product Management, QAD Inc.. QAD Explore 2012. 2. The following is intended to outline QAD’s general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, functional capabilities, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functional capabilities described for QAD’s products remains at the sole discretion of QAD.. Linda Beebe. June 2, 2011. SSP June 2, 2011. SSP June 2, 2011. Collision of 2 Worlds. SSP June 2, 2011. Explosion of─. . Research. . Data. . Accrued Knowledge. Increased Requirements. March 28, 2012. Nina Brown, MPH, CHES, Public Health Analyst, OQD. Michelle Bright, Public Health Analyst, OAM. U.S. Department of Health and Human Services. Health Resources and Services Administration. Luc Janssen. Director, Product Management, QAD Inc.. QAD Explore 2012. 2. The following is intended to outline QAD’s general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, functional capabilities, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functional capabilities described for QAD’s products remains at the sole discretion of QAD.. refers to all of the applications and technologies used to gather, provide access to, and analyze data and information to support decision-making efforts. Putting together all of the pieces of the puzzle. AS9104/2A. &. Special Audit Discussion. Tim Lee. The Boeing Company. Chair, IAQG OPMT. 23 July 2015. Purpose. To provide awareness and understanding of the AS9104/2A criteria for AAQG Member supplemental Certification Body (CB) oversight.. Supplemental Figure 1 Supplemental Figure 2 Supplemental Figure 3 Supplemental Figure 4 Supplemental Table 1 Supplemental Figure 5 ppendix IFuel Transport Memorandum411 CuMoExplorationProject Supplemental Environmental Assessment413 Supplemental Environmental AssessmentCuMoplorationProject 414 CuMoExplorationProject Supplemental DMSs . and dietary intake and lifestyle factors at . exam 5 . for . all participants (n=1880). . -log10 (P value). 60. 50. 40. 30. 20. 10. 132 Nutrients/Bioactive . 129 Food group1 (FFD). 29 Food group2 (FG5Serv). fpkm. ). PD-L1 (. fpkm. ). CD8 (. fpkm. ). Iba1 (. fpkm. ). p. < 0.001. p. < 0.001. p. < 0.001. p. < 0.001. GM-CSF. GM-CSF. GM-CSF. GM-CSF. Supplemental Figure 1. Gene expression analysis in breast cancer cases from TCGA database. Gene expression levels of CD8, Iba1, PD-L1, and PD-L2 in breast cancer were compared between the cases with and without GM-CSF expression. The Mann-Whitney . Scale bar: 10nm. 9.5nm. 14.7nm. Average diameter:. A. B. Supplemental figure 2. ELISA using FT and GnH-FT as antigens. A. B. * P <0.05, ** P<0.01, *** P<0.001, and **** P<0.00001. **. *. *. B. Supplemental Figure 2. Tissue. Adrenal gland . Appendix. Appendix . Bone marrow . Breast . Breast cancer. Bronchus Respiratory . Cartilage. Cerebellum . Cerebellum . Cerebellum . Cerebral cortex. Cerebral cortex. children . aged 2–5 years . in Medicaid receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2011. 0.45-1.40%. 1.41-1.70%. 1.71-2.05%. 2.06-3.38%. SUPPLEMENTAL FIGURE 5. . . Ritu. Rathod. Jennifer Downey. Business Intelligence:. The practice of collecting, integrating and analyzing data. . A process in which raw data can be transformed into useful and meaningful information..